Brigatinib

What is Brigatinib?

TYPES:Generic: BrigatinibBrand:

Brigatinib is indicated for treatment of anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC).

Save up to 80% off your prescriptions!

How do members experience Brigatinib?

Top 5 reported purposes & perceived effectiveness

Purpose Patients Evaluations Perceived Effectiveness
Adenocarcinoma (non-small cell lung cancer) 1 0
Learn more about our community’s experience with Brigatinib

What are people saying about Brigatinib?

2

2

members have reported taking Brigatinib

Join the conversation and connect with people who have taken Brigatinib
Last updated:

Save up to 80% off your prescriptions!

ADVERTISEMENT

ADVERTISEMENT